Table 2.
Distribution of antibiotic resistance pattern according to ESBL production
| Antibiotic | Total no. 129 | ESBLs-positive no. 66 | P-value | ||||
|---|---|---|---|---|---|---|---|
| Susceptible no. (%) | Intermediate no. (%) | Resistant no. (%) | Susceptible no. (%) | Intermediate no. (%) | Resistant no. (%) | ||
| Ampicillin | 24 (18.6) | 4 (3.1) | 101 (78.3) | 0 | 1 (1.5) | 65 (98.5) | <0.001 |
| Amoxicillin-clavulanate | 59 (45.7) | 43 (33.3) | 27 (20.9) | 15 (22.7) | 31 (47) | 20 (30.3) | <0.001 |
| Cefoxitin | 96 (74.4) | 13 (10.1) | 20 (15.5) | 37 (56.1) | 12 (18.2) | 17 (25.8) | <0.001 |
| Cefixime | 49 (38) | 9 (7) | 71 (55) | 1 (1.5) | 0 | 65 (98.5) | <0.001 |
| Ceftazidime | 51 (39.5) | 21 (16.3) | 57 (44.2) | 2 (3) | 9 (13.6) | 55 (83.3) | <0.001 |
| Ceftriaxone | 51 (39.5) | 5 (3.9) | 73 (56.6) | 1 (1.5) | 0 | 65 (98.5) | <0.001 |
| Cefotaxime | 43 (33.3) | 11 (8.5) | 75 (58.1) | 1 (1.5) | 0 | 65 (98.5) | <0.001 |
| Cefepime | 76 (58.9) | 7 (5.4) | 46 (35.7) | 17 (25.8) | 5 (7.6) | 44 (66.7) | <0.001 |
| Ciprofloxacin | 50 (38.8) | 10 (7.8) | 69 (53.5) | 7 (10.6) | 4 (6.1) | 55 (88.3) | <0.001 |
| Ofloxacin | 64 (49.6) | 0 | 65 (50.4) | 13 (19.7) | 0 | 53 (80.3) | <0.001 |
| Nalidixic acid | 27 (20.9) | 6 (4.7) | 96 (74.4) | 3 (4.5) | 0 | 63 (95.5) | <0.001 |
| Aztreonam | 56 (43.4) | 9 (7) | 64 (49.6) | 1 (1.5) | 5 (7.6) | 60 (90.9) | <0.001 |
| Tetracycline | 46 (35.7) | 3 (2.3) | 80 (62) | 13 (19.7) | 2 (3) | 51 (77.3) | <0.001 |
| Gentamicin | 84 (65.1) | 7 (5.4) | 38 (29.5) | 30 (45.5) | 2 (3) | 34 (51.5) | <0.001 |
| Trimethoprim/sulfamethoxazole | 38 (29.5) | 1 (0.8) | 90 (69.8) | 10 (15.2) | 0 | 56 (84.8) | <0.001 |
| Nitrofurantoin | 124 (96.1) | 3 (2.3) | 2 (1.6) | 63 (95.5) | 1 (1.5) | 2 (3) | 0.522 |
| Imipenem | 119 (92.2) | 10 (7.8) | 0 | 60 (90.9) | 6 (9.1) | 0 | 0.402 |